NMT PHARMA has participated in CPhI Worldwide held from 4th to 6th October 2016 at Fira de Barcelona Gran Via Conference Centre. The event hosted more than 36,000 visiting pharma professionals over the three days, and gathered about 2,500 exhibitors from 150 countries. NMT PHARMA featured its contract R&D services and licensing of CZ48 oncology drug development program. The Company’s booth hosted many visitors with great interest in the applications of nano-technology in drug particle processing and formulation. NMT PHARMA’s Inhaled Insulin has attracted many enquiries from visitors of various regions.